The inflammatory micro-environment in tumor progression: The role of tumor-associated macrophages

被引:810
作者
Allavena, Paola [1 ]
Sica, Antonio [1 ,2 ]
Solinas, Graziella [1 ]
Porta, Chiara [1 ]
Mantovani, Alberto [1 ,3 ]
机构
[1] IRCCS Ist Clin Humanitas, Milan 20089, Italy
[2] Fdn Humanitas Ric, Milan 20089, Italy
[3] State Univ Milan, Inst Pathol, Milan 20133, Italy
关键词
tumor-associated macrophages (TAM); inflammation; tumor; cytokines; chemokines; angiogenesis; matrix-metallo proteases (MMP); micro-environment;
D O I
10.1016/j.critrevonc.2007.07.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The link between inflammation and cancer proposed more than a century ago by Rudolf Virchow, who noticed the infiltration of leukocytes in malignant tissues, has recently found a number of genetic and molecular confirmations. Experimental, clinical and epidemiological studies have revealed that chronic inflammation contributes to cancer progression and even predisposes to different types of cancer. Cancer-associated inflammation includes: the presence of leukocyte infiltration; the expression of cytokines such as tumor necrosis factor (TNF) or interleukin (IL)-1; chemokines such as CCL2 and CXCL8; active tissue remodelling and neo-angiogenesis. Tumor-associated macrophages (TAM) are key regulators of the link between inflammation and cancer. Many observations indicate that, in the tumor micro-environment, TAM have several protumoral functions, including expression of growth factors, matrix proteases, promotion of angiogenesis and suppression of adaptive immunity. In this review we will discuss the role of TAM in the inflammatory micro-environment of solid tumors and will try to identify potential target for future therapeutic approaches. (C) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 95 条
  • [51] Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy
    Lin, EY
    Nguyen, AV
    Russell, RG
    Pollard, JW
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (06) : 727 - 739
  • [52] Analysis of the gene expression profile activated by the CC chemokine ligand 5/RANTES and by lipopolysaccharide in human monocytes
    Locati, M
    Deuschle, U
    Massardi, ML
    Martinez, FO
    Sironi, M
    Sozzani, S
    Bartfai, T
    Mantovani, A
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 168 (07) : 3557 - 3562
  • [53] Chemokines - Chemotactic cytokines that mediate inflammation
    Luster, AD
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (07) : 436 - 445
  • [54] Macrophage polarization comes of age
    Mantovani, A
    Sica, A
    Locati, M
    [J]. IMMUNITY, 2005, 23 (04) : 344 - 346
  • [55] THE ORIGIN AND FUNCTION OF TUMOR-ASSOCIATED MACROPHAGES
    MANTOVANI, A
    BOTTAZZI, B
    COLOTTA, F
    SOZZANI, S
    RUCO, L
    [J]. IMMUNOLOGY TODAY, 1992, 13 (07): : 265 - 270
  • [56] Chemokines in the recruitment and shaping of the leukocyte infiltrate of tumors
    Mantovani, A
    Allavena, P
    Sozzani, S
    Vecchi, A
    Locati, M
    Sica, A
    [J]. SEMINARS IN CANCER BIOLOGY, 2004, 14 (03) : 155 - 160
  • [57] The chemokine system in diverse forms of macrophage activation and polarization
    Mantovani, A
    Sica, A
    Sozzani, S
    Allavena, P
    Vecchi, A
    Locati, M
    [J]. TRENDS IN IMMUNOLOGY, 2004, 25 (12) : 677 - 686
  • [58] Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes
    Mantovani, A
    Sozzani, S
    Locati, M
    Allavena, P
    Sica, A
    [J]. TRENDS IN IMMUNOLOGY, 2002, 23 (11) : 549 - 555
  • [59] Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progression
    Mantovani, A
    Allavena, P
    Sica, A
    [J]. EUROPEAN JOURNAL OF CANCER, 2004, 40 (11) : 1660 - 1667
  • [60] Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4
    Marchesi, F
    Monti, P
    Leone, BE
    Zerbi, A
    Vecchi, A
    Piemonti, L
    Mantovani, A
    Allavena, P
    [J]. CANCER RESEARCH, 2004, 64 (22) : 8420 - 8427